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Bone mineral: update on chemical composition and structure
C. Rey & C. Combes & C. Drouet & M. J. Glimcher
History
The structure of the Ca–P solid phase in bone was first
identified by deJong in 1926 as a crystalline calcium
phosphate similar to geological apatite by chemical analyses
and, most importantly, by X-ray diffraction [1]. The X-ray
diffraction data was confirmed a few years later [2].
These findings initiated a flurry of research on a more
detailed chemical composition and crystal structure of both
geological and synthetic apatites and of bone mineral, initially
carried out principally by geologists, crystallographers, and
chemists, but later by biochemists and physiologists because
of the clear potential of this new information to shed light on
the biological and physiological functions of bonemineral and
as indicators of disorders of the skeletal system.
It soon became clear that there were significant structural
and chemical compositional differences between the many
different geological hydroxyapatites, synthetic hydroxyapa-
tites, and the apatite crystals found in bone and related skeletal
tissues in addition to the very large size of the geological and
many of the synthetic apatite crystals, compared with the
extremely small particle size of bone mineral.
Further studies were directed in roughly three avenues:
continued more careful and complete analytical composi-
tional data of bone mineral, from which it was clearly
established that the chemical composition of bone crystals in
many ways did not correspond to the chemical compositions
of stoichiometric hydroxyapatite. Indeed, the bone crystals
were found to contain significant and varying amounts of
carbonate and HPO4 ions. Much later, it was discovered by a
variety of techniques, including solid-state NMR [3], Raman
spectroscopy [4], and inelastic neutron scattering [5], that
the biological bone apatites contain only a very small
percentage of the total number of hydroxyl groups present in
highly purified synthetic calcium hydroxyapatites.
Other studies clearly pointed out that a substantial
fraction of the phosphate ions are situated on the surfaces
of the bone mineral crystals which are mainly protonated
and in a disordered environment [6], in contrast to the
phosphate ions in lattice positions, which are unprotonated.
Also, other uniquely protonated phosphate ions were
identified in bone mineral by phosphorus 31 NMR
spectroscopy, which are not present in synthetic calcium
phosphate apatites [7].
Structural studies were first carried out to determine
crystal size by measuring the extent of X-ray diffraction
peak broadening [8], which yielded crystal sizes varying
from 31 to 290Å. More detailed structural data were
obtained by the then recently introduced field of electron
microscopy and electron diffraction [9–11], which revealed
that the bone crystals were thin plates, approximately 500Å
long, 250Å wide, and 100Å thick. However, calculations
from low-angle X-ray diffraction scattering studies [12–14]
were more consistent with the conclusions that the bone
crystals were very much smaller than those observed by
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Robinson et al. by TEM which were rods 250Å long and
50Å thick and not platelets. Crystal perfection, another
structural property of the individual bone nanocrystals, is
also a function of the extent of mineralization, as
demonstrated by the changes in their wide-angle X-ray
diffraction patterns [15] (Fig. 1).
More accurate evaluations of the size and shape of the
bone crystals were later obtained by the development of
techniques, which removed essentially all of the organic
matrix constituents of the bone samples prior to TEM
without altering the bone crystals, thus permitting their
examination by high-resolution TEM and electron diffrac-
tion as well as 3D stereoscopic TEM, which firmly
established that the bone apatite crystals were indeed
nanosized, very thin, long platelets (nanocrystals), and not
rods [16–18]. This was further confirmed by atomic force
microscopy [19, 20]. Further TEM compositional studies of
the bone crystals from a wide variety of species as a
function of “crystal age” (vide infra) revealed that the initial
Ca–P solid phase deposited consisted of irregular, roughly
round electron dense particles, some as small as ~10Å [21].
These data focused attention on the important physiological
implications of the enormous surface area of the bone
nanocrystals, especially during the early stages of new bone
formation and calcification, and its role in ion homeostasis of
the extracellular fluids. These data demonstrate another
important structural and physical chemical characteristic of
the bone crystals as a function of crystal age (vide infra),
further complicating the problem of quantitatively describing
the bone crystals in a particular sample of bone substance.
Great strides have been made in utilizing in vitro
calcification experiments using purified native collagen
fibrils and metastable solutions of Ca and P to gain
information on the composition and structure of the initial
Ca–P solid phase formed during heterogeneous nucleation.
These have demonstrated that purified natively 3D-packed
collagen molecules in collagen fibrils with an axial period of
approximately 670Å are capable of heterogeneously nucle-
ating apatite crystals in vitro [22–24].
It was hoped that this information on the potential
chemistry and structure of the initial nucleation sites within
the collagen fibril responsible for initiating crystallization
might be obtained from the in vitro nucleation experiments.
The chemical and X-ray diffraction data identifying the
nanocrystals nucleated in vitro by collagen fibrils, including
the specific location of the nanocrystals in an orderly
repeating pattern within the collagen fibrils [25–27], was
later confirmed by wide- and low-angle X-ray diffraction
studies [28]. Much more quantitative in vitro nucleation
experiments were carried out by Katz [29], who quantita-
tively measured the kinetics of in vitro calcification of
native collagen fibrils and established the size of the apatite
nuclei found in his in vitro nucleation studies (~ 20 ions
under the specific conditions of his experiments). Various
schema and experiments were devised from these in vitro
studies of nucleation of the likely composition of the nuclei
(first solid phase Ca–P formed during in vitro calcification)
and the potential role of the phosphoryl groups and glutamic
acid side chains of a particular noncollagenous matrix
protein in bone (bone sialoprotein-BSP) [27, 29, 30, 32].
Very importantly, solid-state 31P NMR analysis of the
youngest sample of native bone available at that time
identified for the first time the presence of a seryl
phosphate-calcium bond, presumably directly linking a
prominent protein in the organic matrix of bone (BSP)
with the mineral phase [33].
A number of other experiments were also devised and
carried out to surmount the problems of how to isolate the
Fig. 1 X-ray diffractometer patterns obtained from bone fractions with
intensity as the ordinate and diffraction angle (2θ) as the abscissa. a
Seventeen-day-old chick embryo periosteal bone. b Five-week post-
hatch chick, 2.1-2.2 g/cm3 density fraction. c Two-year-old chick, 2.2-
2.3 g/cm3 density fraction. d Highly crystalline synthetic hydroxyap-
atite. Patterns derived from rate meter charts obtained with a
continuously scanning diffractometer equipped with a diffracted-beam
monochromator, using CuKα radiation. (From Bonar et al. [70])
very youngest bone mineral crystals in specimens of bone
without introducing any contact of the specimens with
water, which not only very rapidly dissolves the crystals but
also introduces physical and chemical compositional
changes in the crystals which remain in the bone sample.
While the chemical composition and crystal structure,
particle size, degree of crystallinity, etc., of the individual
bone crystals in a specific sample of bone in a particular
location of a particular bone is clearly a significant function
of the age of the animal, a recently introduced new concept
has pointed out that the most significant “time function” as
far as it affects all of the compositional, structural, and
interaction properties and characteristics of bone apatite
crystals is not the age of the animal, but the age of the
individual crystals (crystal age), viz., the elapsed time
between the initial deposition of the crystals and their
removal (resorbtion) from the tissue [31]. The very
significant chemical and structural changes in the solid
mineral phase are primarily a function of crystal age and is
clearly directly related to the very rapid local turnover of
bone substance and its crystals, in many instances over
widely separated local regions of a particular bone.
Other difficulties in accurately determining the chemical
composition and structure of the bone mineral at any one
point of time in a specific location of a particular bone
during its initial formation and subsequent maturation (as a
function of age of the animal and especially crystal age) are
also due to the very complex internal geometric disposition
of the bone substance containing the crystals at all levels of
the anatomical hierarchy, observable by light microscopy to
high-resolution transmission electron microscopy and atom-
ic force microscopy. For example, it is clear from light
microscopy and contact X-ray microscopy that there are
great differences in the mineral content of individual,
immediately adjacent osteons, for example, and in imme-
diately adjacent individual lamellae of a single osteon.
Indeed, transmission electron microscopy and electron
diffractometry and other high-resolution techniques have
highlighted the compositional, structural, and mineral
content differences of the bone mineral substance due to
the marked heterogeneity within various volumes of the bone
substance at all anatomic levels, observable by light micros-
copy to high-resolution TEM, atomic force microscopy, and
even higher levels of resolution.
It was also clear from the early TEM experiments that
the exposure of samples of bone to water introduced
significant dissolution of the bone nanocrystals as well as
phase and compositional changes in many of the remaining
crystals in the samples of bone. It was therefore clear that
the preparation of samples of bone for microscopy at all
levels of resolution and their chemical and physical
properties would all require the preparation and analyses
of samples of bone without exposure to water.
The earliest such experiments were carried out on the
very outermost layers of bone of the midshaft of the long
bones of embryonic chick (and other species) using only
non-aqueous solvents. The bone samples were powdered
and density-separated in non-aqueous solvents. The very
lowest density fractions were first evaluated by wide-angle
X-ray diffraction, chemical composition, and 31P NMR,
revealing the presence of only very poorly crystallized
apatite. There was no evidence of an initially “amorphous
Ca–P solid phase”, which had first been postulated by
Posner et al., which, with time (higher density samples),
underwent either a solid-state phase change to very poorly
crystallized apatite crystals or was first solubilized and then
recrystallized as poorly crystallized apatite crystals [32–36].
Further compositional and structural studies to ascertain the
structure of the initially nucleated bone crystals were carried
out on the intramuscular bones of various species of fish. The
use of these bones containing highly oriented collagen fibrils
provide many important advantages in identifying the location
and nature of the first Ca–P solid phase formed very
accurately at high resolution. Using high-definition
synchrotron-generated X-ray diffraction and FTIR, and the
simultaneous measurement of the concentrations of calcium
and inorganic phosphorus at the same sites [37] clearly
established that the earliest Ca–P solid phase deposited
during the calcification of the fish bones is a very poorly
crystalline solid phase of apatite, similar to the results
obtained from the earliest detectable Ca–P mineral phase
found in chick and other species. Note that the earliest solid Ca–
P mineral phase in the fish bones was obtained from freshly
caught fish immediately frozen while alive in liquid nitrogen
and examined using a temperature-cooled stage.
The location of the nanocrystals of bone mineral in bone
substance
A good deal of attention has also been focused more
exactly on where the nanocrystals are located in the bone
substance as a function of time, the varying distribution of
the crystals within the collagen fibrils, and their effect on
the biological and mechanical properties of the different
locations within the collagen fibrils as a function of time.
First, essentially all of the bone crystals are formed within
the collagen fibrils, initially at specific repeating locations
along the approximately 670Å longitudinal repeat period of
the individual collagen fibrils. The process of initiating the
formation of the crystals is now universally accepted to be
initiated by a process of heterogeneous nucleation [21–23].
Continued nucleation of more crystals and the growth of
the previously deposited crystals eventually occupy “all” of
the free space within the bone collagen fibrils. This
essentially converts bone substance to a composite struc-
tural material with important and changing critical physio-
logical functions and with changing mechanical, chemical,
and interaction properties as a function of the changing
location(s) of the nanocrystals within the collagen fibrils
and the extent of collagen fibril mineralization. For
example, we note the frequent misunderstanding of the
implications of a substance or material being a “composite”.
It is not simply that the mechanical, chemical, electrical, etc.
properties of the composite material can be markedly altered
simply by the addition of the different properties of each of the
individual components, but instead by the geometric spatial
relationships between the individual layers, for example, and
by the nature and strength of the forces and interactions
between the individual separate components. Thus, one
misses the point of constructing a composite material if all
one intends to accomplish is to add together the various
properties of the individual components of the composite. For
example, if one is dealing with bone substance as a composite
material, its mechanical properties cannot be attributed solely
to the mechanical properties of the individual components of
which it is constructed, i.e., that the collagen fibrils contribute
the longitudinal tensile strength properties to the composite,
the crystals contribute the compression properties, etc. The
mechanical properties of the composite are due principally to
the spatial relationships between the various layers and the
interactive forces between the two (or more) such layers, viz.,
collagens, mineral crystals, chemical, and other forces
between the two (or more) components, etc.
Synthetic calcium phosphate crystals
What we have tried to emphasize thus far is that despite
taking advantage of the expanding technological advances
in observing and measuring the properties of the nano-
crystals of bone and synthetic apatites and the theory,
practice, and understanding of phase transformations, the
myriad of complexities in describing and measuring the
composition and structure of the bone mineral and their
interaction properties with other components, and the
changes in the nanocrystals, which occur very rapidly as a
function of crystal age, all of which are dependent on the
gross location of the specific bone and microscopic and
ultrastructural distribution of the sample to be analyzed,
have made it impossible to describe a single chemical
composition and structure of the nanosized “bone mineral”
crystals, except in very general terms.
For example, one of the main difficulties in correctly
describing the chemical composition of bone apatites is due
to a lack of very accurate chemical analytic techniques to
measure the complicated chemical compositions. For
example, the amounts of HPO4
2− and OH− ions in samples
of bone apatite cannot be measured by chemical analytic
techniques with sufficient accuracy to define their compo-
sition. In addition, mineralized tissues often contain
numerous trace elements, which replace other constituents
of the bone substance tissue and its crystals [39]. Some of
these trace elements are closely related to the solid mineral
phase (F−, Sr 2+), others are primarily present in the organic
matrix (Si, Cu for example), and others such as Zn may be
located in both the solid mineral phase and/or in the organic
matrix. Very often, however, such trace elements cannot
even be accurately located in specific components in bone
substance. Yet, another very important difficulty encoun-
tered is the presence of a hydrated surface layer of both bone
crystals and synthetic apatite crystals, which contain varying
concentrations of a wide variety of mineral ions [40].
As a result of these difficulties, a number of investigators
have directed their research to the properties of synthetic
highly crystalline calcium apatites. Indeed, some of the
most significant progress in understanding important
structural and chemical properties of the biological bone
apatites (nanocrystals) have been derived from such
research on synthetic calcium apatites or in some instances
from naturally occurring geological apatites.
It is important to note that the specific physiological,
chemical, structural, and interactive properties of native
bone mineral nanocrystals are not derived from the lattice
structure of stoichiometric hydroxyapatite but rather from
specific lattice substitutions and ion vacancies [3–6].
Composition of synthetic calcium phosphate apatites
The composition of synthetic calcium apatites is very
complex and, in most cases, more complex than in biological
apatites due to multiple lattice substitutions and the presence
of varying numbers of ion vacancies [41]. The most relevant
of these substitutions in biological apatites are the replace-
ment of the PO4
3 anions by bivalent species, HPO4
2− and
CO3
−2, which have also been detected in large and variable
amounts in samples of bone mineral [42–45].
Chemical analyses of synthetic calcium apatites have
revealed a common charge compensation mechanism
containing these bivalent ions, which are created by two
ionic vacancies: one of which is on a cationic site and the
other on a monovalent anionic site according to the general
chemical formula: Ca10−x (PO4)6−x (HPO4 or CO3)x (OH)2−x
[46]. The validity of these charge compensation mechanisms
has been recently confirmed by Rietveld analyses of X-ray
diffraction patterns of substituted synthetic apatites [47, 48].
In addition, the cationic vacancy has been shown to occur
mainly on the Ca (II) site in close proximity to monovalent
anionic sites [49], suggesting the existence of clusters of
vacancies that are often observed in compounds with a large
number of vacancies in accordance with Pauling's rules of
the local charge compensation in the lattice (Fig. 2). This
substitution process explains in part the low concentration of
OH− ions detected in large synthetic apatites and bone
mineral apatites [44]. However, Raman spectroscopy of rat
bone indicates only a few percent of the predicted
concentration of OH− ions in bone apatites [4]. These studies
have indeed provided some of the most significant new
information on the possible structure, composition, and
reactivity of the nanocrystals of bone mineral derived from
research on synthetic calcium apatites. These induced
variations in the composition of the apatites occur at all
stages of the “age” of the crystals. Although most of the
changes are due in large part to multiple ion substitutions and
vacancies, an additional phenomenon observed in synthetic
apatites, which may also be found in biological apatites,
consists of the internal hydrolysis between PO4
3− ions and
water molecules in the solid phase [2, 38, 39]:
PO34 þ H2O! HPO24 þ OH:
This reaction has also been found to occur in synthetic
amorphous calcium phosphate (ACP) [12] and octacalcium
phosphate (OCP) [13] and could be present in non-
stoichiometric apatites. It would be limited, however, by
the number of OH− vacancies, leading to the following
chemical formula:
Ca10x PO4ð Þ6xy HPO4ð Þxþy OHð Þ2xþy:
Non-apatitic environments in bone mineral
Spectroscopic studies of bone mineral have not only detected
the presence of the components of apatite but also the
existence of mineral ions in non-apatitic arrays [50–53].
Spectroscopic studies of synthetic nanocrystalline calcium
apatites have shown that these ions are also located in a
hydrated layer on the surfaces of the crystals [54]. The
Oxygen
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Fig. 2 Charge compensation
mechanism in type B carbonate-
and HPO4
2--containing apatites
explaining the OH− deficit.
The replacement of a PO4
3− ions
by bivalent species is associated
with a cationic vacancy in Ca2+
sites (type II) and a vacancy in
the monovalent OH− site
(according to Labarthe et al.
[49])
surface hydrated layer of synthetic apatite nanocrystals
contains mainly bivalent ions, a large proportion of which
are CO3
2− and HPO4
2− ions (Fig. 3). However, carbonate
and HPO4
2− ions have also been found in apatitic domains.
These findings make it necessary to revise the chemical
composition of bone apatite crystals based on well-
crystallized, large non-stoichiometric synthetic apatites,
which do not include the composition of their hydrated
surface layer. Interesting data obtained by NMR of synthetic
apatites [55] suggest that as much as 55% of the total
inorganic phosphate ions reside on a disturbed surface layer
of synthetic apatite nanocrystals.
Little is known about the structure of this hydrated layer
on the surface of synthetic calcium apatites. Additional
spectroscopic analyses of wet samples of synthetic calcium
apatite crystals have shown that the hydrated surface
produces narrow but specific spectroscopic bands depending
on its composition [56]. For example, importantly, the FTIR
spectra of wet synthetic nanocrystals containing HPO4
2−
have been found to be very similar but not identical to OCP,
while 31P solid-state NMR spectra are very different from
those of octacalcium phosphate and contain HPO4
2− environ-
ments very similar to those of dicalcium phosphate dihydrate
(DCPD) [56].
These data illustrate the difficulty of identifying even the
non-apatitic environments of synthetic Ca–P apatites.
Moreover, the differences found depend on the techniques
used to examine these environments. Importantly, the
spectroscopic data of synthetic apatites have also been
shown to be very sensitive to partial and complete drying.
For example, the spectroscopic peaks are not completely
preserved in dry samples, which exhibit only a single broad
spectroscopic band of an amorphous-like mineral phase
[56]. Furthermore, depending on the experimental condi-
tions, the non-apatitic structure in the same sample has been
identified as DCPD using solid-state NMR, OCP by FTIR,
and ACP in fully dried samples!
From similar experiments, investigators also concluded
that a DCPD-like structure was also present based on 31P
solid-state NMR of bone [49] although XRD and electron
diffraction failed to detect a separate DCPD phase. More
recent solid-state NMR studies on completely dried bone
samples have given more ambiguous results: the presence
of HPO4
2− ions, which exhibit a chemical shift of HPO4
2−
species very similar to that of OCP but a chemical shift
anisotropy closer to that of DCPD! [7].
It is very interesting that studies of biological mineral-
ization of invertebrates have in many ways paralleled
those in bone and other vertebrate tissues in most
instances, but differ significantly in many aspects. Impor-
tantly, the tissues are mineralized by the deposition of a
solid phase of CaCO3 [57], and not by crystals of calcium
phosphate [58–61]. Weiner’s group has contributed a very
significant number of important original contributions in
this field, clearly demonstrating that the initial solid phase
of CaCO3 deposited in these tissues is an amorphous solid
phase, which later undergoes a solid phase transition to
large, highly crystalline CaCO3 (calcite or aragonite), or
was solubilized and recrystallized as highly crystalline
calcite or aragonite. However, whether or not these data of
an initial “precursor” phase of CaCO3 that is first
deposited in the tissue and later converts to highly
crystalline calcite or aragonite does not necessarily follow
that this same sequence occurs in all biologically miner-
alized tissues. The theory that a solid amorphous precursor
mineral phase is formed prior to the formation of a
crystalline mineral phase [34] has not been substantiated
in bone [62].
For example, we have already presented the data, some
of which appears in this contribution, which demonstrated
that we were unable to detect the presence of a precursor
amorphous solid Ca–P phase in bone prepared anhydrously
and analyzed by scanning the entire length of the long thin
bone(s) by synchrotron-generated X-ray diffraction until the
very first small region of the bone, which first generates a
wide-angle X-ray diffraction pattern. This region is then
bracketed, and the leading edge of the region is once again
analyzed by synchrotron-generated wide-angle X-ray
diffraction. This was repeated until there was only a
barely visible diffraction pattern. The X-ray apparatus was
then focused a very small distance away from the faint X-
ray diffraction reflections, and the tissue exposed to
further wide-angle X-ray diffraction for a much larger
period. The X-ray diffraction pattern clearly identified
very poorly crystalline apatite. The sequence was again
Apatite
core
Hydrated
layer
Ca2+
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Fig. 3 Schematization of apatite nanocrystals of bone mineral. The
core of the crystals is a non-stoichiometric apatite lattice. At the
surface, a structured hydrated layer contains loosely bound ions,
which can be incorporated in the growing and more stable apatite
domains (arrows). The ions of the hydrated layer can be easily and
reversibly exchanged by ions of the surrounding fluids or charged
groups of proteins (Pr) determining the surface reactivity and surface
interactions involving the nanocrystals
repeated and similarly identified as poorly crystalline
apatite. No evidence was obtained for the presence of
any other phase of Ca–P crystals.
Precursor phase(s) of apatitic nanocrystals
A recent paper concerning possible Ca–P “precursor phases”
formed prior to the formation of poorly crystalline calcium–
phosphate apatites in bone has been published [64]. In these
experiments, the authors utilized an ingenious and very
clever experimental protocol using newly synthesized living
intramembranous cranial bone in the suture lines and
analyzed the tissue by Raman microspectroscopy. The
authors identified several distinct “transient” Ca–P solid
phases of octacalcium phosphate (OCP) or “OCP-like solid
phases” as well as other components such as an ACP solid
phase. These early solid phases of Ca–P contain large
numbers of carbonate ions in non-apatitic environments. The
existence of carbonate ions in OCP is not compatible with
the identification of such Ca–P mineral crystals containing
OCP since no carbonate-containing OCP crystals or other
non-apatite crystalline phases containing carbonates have
hitherto been identified [40].
Also, there is no explanation for the presence of OCP or
an “OCP-like” solid phase by spectroscopy of so-called
precursor phases different from apatites if one utilizes only
one particular ion compound to identify the solid phase. For
example, similar analyses of the FTIR-PO4 bands of apatite
nanocrystals and those of OCP, which when present can be
definitely identified by the most specific spectroscopic band
of phosphate ions at 915 cm−1 and which has never been
detected in samples of bone or in the mineral phase, formed
in vivo during the stimulation of new bone in the
intracranial substance [65]. We do not feel that the
conclusion that OCP or “OCP-like” crystals exist in bone
as distinct crystalline phases and can account for the very
large number of non-apatite environments found in newly
formed bone mineral at any stage of new bone formation.
As already mentioned, the earliest formed crystals are
very unstable and readily transformed to other phases such
as OCP or DCPD after short exposures to water. In this
instance, we note that OCP and “OCP-like” solid phases
and other solid Ca–P solid phases were also subjected to
exposure to water during the formative period and again
before and during the spectroscopies—ample time to
convert young newly formed Ca–P phases to OCP or
“OCP-like” crystals and ACP, etc. [41].
The publication of the paper by Crane et al. [65] elicited
several sharp responses. Weiner [63] commented that at
long last, experimental evidence had finally been obtained
that the initial solid phase of Ca–P formed during the
calcification of bone was not a poorly crystalline apatite
but, rather, like the calcification of invertebrate shells by
CaCO3, the initial solid phase of Ca–P formed in bone was
an amorphous Ca–P, only later replaced by poorly
crystalline apatite. Unfortunately, the Raman spectroscopy
data obtained by Crane et al. [65] actually showed that the
major Ca–P solid phases first detected were OCP or OCP-
like “crystals”, as well as “other” minor unidentified Ca–P
solid phases such as amorphous ACP.
A reply [64] to the original publication by Crane et al. [65]
and to the editorial by Weiner [63] was critical of both the
original publication [65] and Weiner's editorial [63]. The
authors of the present paper also have some serious
misgivings about the interpretations of Crane et al. [65], and
our admonitions that one is dealing with the formation of a
solid phase consisting of only a very small number of ions
(nanocrystals) whose interaction properties are, importantly,
distinct from those of classical, physical chemistry of
large-sized crystals [31].
No X-ray, electron, or neutron diffraction evidence has
ever reproducibly provided data supporting this hypothesis
presented by Crane et al. [65]. In addition, a careful
examination of spectroscopic data obtained by different
techniques and an exploration of all spectroscopic charac-
teristics (not only special features) does not support the
existence of separate crystalline phases different from those
of apatite, even in the youngest samples of bone from the
youngest animals. For example, despite some analogy
between the FTIR PO4 bands of apatite nanocrystals and
that of OCP, the most specific FTIR band of OCP at
915 cm−1 has never been detected in such samples of bone
[56]. We conclude that OCP as a distinct crystalline phase
has not been detected in bone. Also, no spatially specific
phase other than apatite can account for the very large
quantity of non-apatitic environments found in bone
mineral. In addition, the initially formed apatite nano-
crystals of bone mineral are very unstable, especially when
first formed in embryonic bone, and can readily undergo a
phase transition in the presence of water to other phases
such as OCP and DCPD, which have occasionally been
identified [66]. Another aspect to consider is the presence
of large amounts of carbonate ions in non-apatitic environ-
ments. As already noted, these ions is not compatible with
the formation of OCP crystals, and to date, no carbonate-
containing OCP crystals or other non-apatitic phases have
been detected. Regarding the reactivity of nanocrystalline
apatites, especially as it relates to non-apatitic environ-
ments, it also differs remarkably from OCP in its very large
capacity for ion exchange: Calcium can be replaced by
magnesium (up to 8.5%) or strontium (up to 20%), and
HPO4
2− ions can be exchanged by carbonate (up to 44%)
with minor changes in the X-ray diffraction patterns and its
crystal appearance [67, 68]. We conclude that the non-
apatitic environments detected by spectroscopic methods
should not be confused with the existence of precursor
crystalline phases different from those of apatite, especially
when only one type of ion is considered.
However, a recent publication has reported that a solid
amorphous Ca–P phase is a major component in the
forming fin bones of Zebra fish and may be a precursor
Ca–P mineral phase that later “transforms” into mature
crystalline Ca–P apatite [69]. We have previously published
extensive studies of the intramuscular bones of several
species of fish by high-resolution synchrotron X-ray
diffraction, FTIR, and other techniques to determine the
nature of the Ca–P deposited, viz., starting from
the unmineralized portion of the thin long fish bones to
the junction of the uncalcified portion of the bone and the
first detection of Ca–P mineral. The intramuscular bones
were obtained from freshly caught live fish, which were
immediately frozen alive in liquid nitrogen, and the
dissected bones were analyzed on cold stages. The first
evidence obtained of the presence of the solid Ca–P deposit
was definitively identified as very poorly crystalline Ca–P
apatite. There was no evidence of an amorphous calcium
phosphate solid phase.
We also note the following reservations we have about the
conclusions reached by Mahamid et al. [69]: The FTIR band
at 961 cm-1 is characteristic of apatite and not carbonated
apatite; this band is also due to phosphate ions in any HPO4
2-
or carbon-containing apatite. Amorphous Ca–P generally
generates a broad band at 950 (10 cm-1) lower than apatite. It
is not present in the FTIR spectrum presented by Mahamid et
al. [69]. This spectrum is sometimes difficult to record and
may require further deconvolution or decomposition of the
FTIR data to detect it.
Another major issue involves the use of sodium hypo-
chlorite, which is very prone to cause precipitation of an
amorphous Ca–P solid phase. This can easily be demon-
strated by adding sodium hypochlorite to serum or plasma.
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